Availability of data and materials Data can be shared through application. For further information please refer to the application forms on the website http://www.cfas.ac.uk/cfas-i/data/#cfasi-data-request. Acknowledgments We would like to thank the MRC CFAS study group for data collection and management. We are also grateful to all respondents, their families and their primary care teams for their participation in the MRC CFAS. We would like to thank Mr. Barry Plumpton, Mrs. Ann McLauchlan, Mrs. Barbara di Vita, and Mrs. Gloria Swan for providing valuable assistance in interpretation and oversight as Alzheimer’s Society Research Network Volunteers. Funding This work was supported by the UK Alzheimer’s Society [AS-PG-2013-017]. The funders ...
Funding Sources: This work was supported by the Alzheimer’s Society UK [AS-PG-2013-017]. The study f...
Objective: To examine the association between benzodiazepine use and the risk of dementia. Design,...
BACKGROUND: The role of modifiable risk factors for patients with dementia and at risk of dementia ...
BACKGROUND: Studies suggest that anticholinergic medication or benzodiazepine use could increase dem...
Background: Studies suggest that anticholinergic medication or benzodiazepine use could increase dem...
BACKGROUND: Studies suggest that anticholinergic medication or benzodiazepine use could increase dem...
Objectives: To examine the association of benzodiazepines and anticholinergic drug usage with the ri...
OBJECTIVES: To estimate the association between the duration and level of exposure to different clas...
Importance Anticholinergic medicines have short-term cognitive adverse effects, but it is uncertain...
Importance: Anticholinergic medicines have short-term cognitive adverse effects, but it is uncertai...
Objectives: To estimate the association between the duration and level of exposure to different clas...
Objectives: To estimate the association between the duration and level of exposure to different clas...
Acknowledgements: We would like to thank the UK Medical Research council CFAS study group for data c...
IMPORTANCE Anticholinergic medicines have short-term cognitive adverse effects, but itis uncertain w...
This research was funded by the UK Alzheimer’s Society grant AS-PG-2013-017.Peer reviewedPublisher P...
Funding Sources: This work was supported by the Alzheimer’s Society UK [AS-PG-2013-017]. The study f...
Objective: To examine the association between benzodiazepine use and the risk of dementia. Design,...
BACKGROUND: The role of modifiable risk factors for patients with dementia and at risk of dementia ...
BACKGROUND: Studies suggest that anticholinergic medication or benzodiazepine use could increase dem...
Background: Studies suggest that anticholinergic medication or benzodiazepine use could increase dem...
BACKGROUND: Studies suggest that anticholinergic medication or benzodiazepine use could increase dem...
Objectives: To examine the association of benzodiazepines and anticholinergic drug usage with the ri...
OBJECTIVES: To estimate the association between the duration and level of exposure to different clas...
Importance Anticholinergic medicines have short-term cognitive adverse effects, but it is uncertain...
Importance: Anticholinergic medicines have short-term cognitive adverse effects, but it is uncertai...
Objectives: To estimate the association between the duration and level of exposure to different clas...
Objectives: To estimate the association between the duration and level of exposure to different clas...
Acknowledgements: We would like to thank the UK Medical Research council CFAS study group for data c...
IMPORTANCE Anticholinergic medicines have short-term cognitive adverse effects, but itis uncertain w...
This research was funded by the UK Alzheimer’s Society grant AS-PG-2013-017.Peer reviewedPublisher P...
Funding Sources: This work was supported by the Alzheimer’s Society UK [AS-PG-2013-017]. The study f...
Objective: To examine the association between benzodiazepine use and the risk of dementia. Design,...
BACKGROUND: The role of modifiable risk factors for patients with dementia and at risk of dementia ...